z-logo
Premium
Phosphorothioate‐modified C p G oligodeoxynucleotides mimic autoantigens and reveal a potential role for T oll‐like receptor 9 in receptor revision
Author(s) -
Doster Anne,
Ziegler Saskia,
Foermer Sandra,
Rieker Ralf Joachim,
Heeg Klaus,
BekeredjianDing Isabelle
Publication year - 2013
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/imm.12063
Subject(s) - receptor , breakpoint cluster region , biology , b cell receptor , toll like receptor 9 , toll like receptor , interleukin 21 receptor , receptor expression , tlr9 , microbiology and biotechnology , immunology , antibody , b cell , gene , gene expression , genetics , innate immune system , dna methylation
Summary Re‐expression of recombinase activating genes ( RAG ) in mature B cells may support autoreactivity by enabling revision of the B ‐cell receptor ( BCR ). Recent reports suggest that administration of T oll‐like receptor 9 ( TLR 9) ‐stimulating C p G oligodeoxynucleotides ( ODN ) could trigger the manifestation of autoimmune disease and that TLR are involved in the selection processes eliminating autoreactive BCR . The mechanisms involved remain to be elucidated. This prompted us to ask, whether TLR 9 could be involved in receptor revision. We found that phosphorothioate‐modified C p G ODN ( C p G PTO ) induced expression of K u70 and re‐expression of RAG ‐1 in human peripheral blood B lymphocytes and I gλ expression in sorted I gκ + B cells. Further results revealed unselective binding specificity of C p G PTO ‐induced immunoglobulin and suggested that C p G PTO engage and/or mimic I g M receptor signalling, an important prerequisite for the initialization of receptor editing or revision. Altogether, our data describe a potential role for TLR 9 in receptor revision and suggest that C p G PTO could mimic chromatin‐bearing autoantigens by simultaneously engaging the BCR and TLR 9 on I g M + B cells.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here